This week CDC discusses vaccine recommendations; a provider offers insights on administering live biotherapeutics; and early administration of simnotrelvir plus ritonavir shortened the time to sustained resolution of COVID-19 symptoms.
Collaborative HCV Care with Pharmacists Could Address System-Level Treatment Barriers
World Hepatitis Day: Where Do We Go From Here?
Fear, Misconceptions Discourage International Hepatitis B and C Testing
Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir
Early Intervention with Tenofovir Alafenamide Reduces Risk of Adverse Effects in Hepatitis B Patients
In Response to Outbreak, 2-Dose Hepatitis E Vaccines Shows High Efficacy